What Unitree’s IPO Means for China’s Humanoid Robot Industry

Unitree Robotics is moving from one of China’s best-known private robotics companies into a public-market benchmark for the country’s humanoid robot industry.

On August 6, Unitree priced its Shanghai IPO at RMB 150.80 per share, valuing the company at roughly RMB 61 billion. The company is seeking to raise about RMB 6.1 billion by selling approximately 40.45 million new shares on the STAR Market, according to Reuters. The deal is set to make Unitree the first mainland-listed manufacturer focused on humanoid robots.

That matters beyond Unitree itself.

China’s humanoid robot sector is moving from venture funding, prototypes and technology demonstrations toward a stage where companies will increasingly be judged on revenue, robot deliveries, margins, real-world deployment and returns on capital.

For investors following the listing itself, MEXC also has separate guides covering the Unitree IPO date and subscription process, Unitree IPO price and valuation, and when Unitree shares may begin trading.

Why Does the Unitree IPO Matter for China’s Robotics Industry?

The most immediate impact is that Unitree gives investors a new valuation and financial benchmark for humanoid robotics.

Before public listings, private robotics companies can often be valued primarily around technology, funding rounds, product demonstrations or long-term market expectations. A listed company faces a different standard.

Investors can compare revenue growth, gross margins, R&D spending, cash flow and robot sales from one reporting period to the next.

Unitree already provides an unusually useful example because its humanoid robots have moved beyond a negligible revenue contribution. In 2025, humanoid robot revenue reached approximately RMB 867.8 million and accounted for 51.78% of Unitree’s main-business revenue. The company recognized sales of 5,215 humanoid robots during the year.

That does not prove that the broader humanoid robot industry has reached mass adoption. It does show that investors can now evaluate at least one major Chinese player using commercial results rather than demonstrations alone.

Unitree Could Accelerate the Robotics IPO Pipeline

Unitree is also arriving at a time when Chinese policymakers and capital markets are increasing support for strategic technology companies.

In June 2026, Chinese regulators announced measures to support listings by companies in “future industries,” while robotics was among the emerging sectors highlighted for capital-market support. The STAR Market has also been adapting listing rules to accommodate strategically important technology businesses.

Unitree is not the only robotics company moving toward public markets.

UBTech has already listed in Hong Kong, while other Chinese robotics companies have also pursued mainland or Hong Kong listings. The Shanghai Stock Exchange has highlighted IPO activity involving companies such as Leju Robotics and DEEP Robotics as competition in embodied AI intensifies.

The implication is not that every humanoid robot startup will now go public. Instead, successful listings could give later companies a clearer reference point for valuation, disclosure standards and investor expectations.

For venture investors, that may also create a more visible path from private funding to public-market liquidity.

The Industry Is Moving From Demonstrations to Commercialization

China’s humanoid robot industry has spent several years attracting attention through walking, running, dancing and increasingly sophisticated manipulation.

The next stage is harder: robots need to perform useful tasks repeatedly in real operating environments.

China’s Ministry of Industry and Information Technology and the State-owned Assets Supervision and Administration Commission launched a 2026 initiative focused specifically on real-world training for humanoid robots and embodied intelligence. The program is intended to promote regular deployment in real production and living environments and accelerate large-scale development.

That policy direction matches what public investors are likely to demand after Unitree’s IPO.

The important metrics will increasingly shift from “What can the robot demonstrate?” toward questions such as:

Can customers use it repeatedly? Can the manufacturer deliver thousands of units? Are prices falling fast enough to expand adoption? Can margins remain sustainable as competition intensifies?

Unitree’s own numbers already illustrate this transition.

The average selling price of its humanoid robots declined from approximately RMB 593,400 in 2023 to RMB 166,400 in 2025, while recognized sales increased from only five units to 5,215 units. At the same time, humanoid robot gross margin declined from the unusually high early-stage level of 87.67% to 63.18%.

The industry therefore faces a familiar commercialization trade-off: lower prices can expand the addressable market, but companies must reduce costs and increase production efficiency to protect profitability.

AI Models Are Becoming More Important to the Robot Industry

Unitree’s IPO also highlights another shift: competition is moving beyond robot hardware.

Humanoid robots need mechanical design, motors, actuators and motion control, but useful general-purpose machines also need models that can interpret environments, understand instructions and translate them into physical actions.

That connection became more visible around Unitree’s IPO when Chinese AI company DeepSeek invested RMB 140.8 million through the strategic placement and agreed to cooperate with Unitree on AI models for humanoid machines.

According to the companies’ exchange filing, the cooperation is intended to combine DeepSeek’s AI-model capabilities with Unitree’s experience in mechanical engineering, motion control and embodied intelligence.

For the wider industry, this suggests that competition may increasingly develop around the combination of three layers: robot hardware, embodied-AI models and real-world training data.

Unitree’s own IPO investment plan follows the same direction. Its disclosed fundraising projects emphasize intelligent robot models, robot-body technologies and new robot products, alongside a new manufacturing base.

Funding May Shift Toward Companies That Can Show Real Revenue

Robotics has attracted significant private investment because the potential market is large. Public markets are likely to impose a more demanding filter.

Unitree entered its IPO with audited 2025 revenue of approximately RMB 1.70 billion, positive net profit and positive operating cash flow. Human-shaped robots had already become its largest revenue category.

That gives future robotics IPO candidates a higher commercial benchmark.

A company may have advanced technology, but public investors are also likely to ask how many robots it sells, how much revenue those robots generate, whether customers return, whether gross margins are sustainable, and how much capital is required to expand production.

This does not mean early-stage companies without profits will disappear from capital markets. China has explicitly been working on listing frameworks for strategically important technology businesses, including companies that may not yet meet traditional profitability requirements.

But the existence of a profitable listed peer such as Unitree may make financial comparisons much easier.

What Could Change for China’s Humanoid Robot Supply Chain?

A larger public robotics sector could also affect companies outside the robot manufacturers themselves.

Scaling humanoid robots requires motors, reducers, actuators, sensors, batteries, computing hardware, dexterous hands, machine vision systems and other components.

Unitree’s own procurement data show that mechanical parts, electronic components and electrical materials represent the majority of its raw-material purchases. However, its supplier base is relatively diversified: the five largest raw-material suppliers accounted for only 22.54% of purchases in 2025.

As robot production grows across the industry, component suppliers may receive more opportunities. But investors should distinguish actual supply relationships from broad “humanoid robot concept stock” narratives.

A company operating in motors, sensors or robotics components is not automatically a Unitree supplier or a beneficiary of Unitree’s IPO.

That distinction is explored separately in Unitree IPO Beneficiary Stocks: Who Really Owns Unitree and Which A-Share Links Are Real?.

What Are the Biggest Challenges After the Unitree IPO?

The listing does not mean the humanoid robotics industry has solved its biggest commercial problems.

Robots still need to become more reliable in unstructured environments. Companies need more real-world training data, better embodied-AI models and lower hardware costs. Manufacturers also need to prove that customers will deploy robots repeatedly rather than purchasing them mainly for research, demonstrations or pilot projects.

Price competition is another risk.

Unitree has already lowered average robot prices significantly while expanding volumes. If the wider Chinese market follows the same direction, lower prices could accelerate adoption but also create pressure on manufacturers that cannot reduce costs fast enough.

International market access is another uncertainty. Reuters reported that changing U.S. restrictions on foreign humanoid and quadruped robots could affect future Unitree products and overseas growth.

The industry therefore still needs to prove three things at the same time: technological capability, scalable manufacturing and repeatable commercial demand.

What Should Investors Watch Next?

After Unitree enters the public market, its quarterly and annual disclosures could become an important reference point for the Chinese humanoid robot sector.

Robot sales growth will matter, but so will average selling prices and gross margins. Investors can also watch how quickly humanoid robots move into industrial and commercial applications, whether R&D spending produces stronger embodied-AI capabilities, and how quickly manufacturing capacity expands.

The broader IPO pipeline will matter as well. More listed robotics companies would make it easier to compare business models, valuations and commercialization strategies across the sector.

Unitree’s IPO therefore should not be read as proof that humanoid robots have reached mass adoption. It is better viewed as another step in the industry’s transition from a venture-funded technology theme toward a measurable commercial sector.

Trade UNITREE Pre-IPO Futures on MEXC

Investors seeking market exposure around Unitree before its shares begin regular public trading can access the UNITREEUSDT Pre-IPO perpetual futures contract on MEXC.

UNITREEUSDT allows eligible users to take long or short exposure to UNITREE’s market-implied reference price. It is a derivative contract, not Unitree stock, and does not provide company ownership, voting rights, dividends or other shareholder rights.

The futures price may differ from Unitree’s IPO offer price and the price at which its shares ultimately trade on the STAR Market. Available leverage, position limits and regional availability are subject to the latest information shown on the MEXC contract page.

Readers new to the company can also review What Is Unitree Robotics? How to Buy and Short It on MEXC.

Frequently Asked Questions

Why is the Unitree IPO important for China’s humanoid robot industry?

Unitree provides one of the first mainland public-market benchmarks for a major humanoid robot manufacturer. Investors will be able to track revenue, robot sales, margins, R&D and commercialization using regular public disclosures.

Is China supporting humanoid robot commercialization?

Yes. In 2026, Chinese authorities launched initiatives focused on deploying humanoid robots and embodied intelligence in real production and living environments, with the aim of accelerating real-world training and larger-scale adoption.

Are humanoid robots already a commercial business for Unitree?

Yes. Humanoid robots generated approximately RMB 867.8 million in revenue in 2025 and represented 51.78% of Unitree’s main-business revenue. However, this does not mean the wider industry has already reached mass adoption.

Will more Chinese robotics companies pursue IPOs?

Several Chinese robotics companies are already pursuing mainland or Hong Kong listings, while regulators have increased support for strategically important technology and future-industry companies. Unitree could provide another valuation and disclosure benchmark for future listings.

Can investors trade UNITREE before public stock trading begins?

MEXC offers UNITREEUSDT Pre-IPO futures. The product is a derivative contract rather than Unitree shares and does not provide shareholder rights.